E3 ubiquitin ligase HECTD2 mediates melanoma progression and immune evasion. (2021)

First Author: Ottina E
Attributed to:  Enhancing immunogenicity in non-viral low mutation burden tumours funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41388-021-01885-4

PubMed Identifier: 34145398

Publication URI: http://europepmc.org/abstract/MED/34145398

Type: Journal Article/Review

Volume: 40

Parent Publication: Oncogene

Issue: 37

ISSN: 0950-9232